The DOI matches its Crossref record; 160 of the 163 references it cites were found in a registry or an index.
Neurological phenotypes for Down syndrome across the life span
Open accessAbstract
This chapter reviews the neurological phenotype of Down syndrome (DS) in early development, childhood, and aging. Neuroanatomic abnormalities in DS are manifested as aberrations in gross brain structure as well as characteristic microdysgenetic changes. As the result of these morphological abnormalities, brain circuitry is impaired. While an intellectual disability is ubiquitous in DS, there is a wide range of variation in cognitive performance and a growing understanding between aberrant brain circuitry and the cognitive phenotype. Hypotonia is most marked at birth, affecting gait and ligamentous laxity. Seizures are bimodal in presentation with infantile spasms common in infancy and generalized seizures associated with cognitive decline observed in later years. While all individuals have the characteristic neuropathology of Alzheimer's disease (AD) by age 40 years, the prevalence of dementia is not universal. The tendency to develop AD is related, in part, to several genes on chromosome 21 that are overexpressed in DS. Intraneuronal accumulation of β-amyloid appears to trigger a cascade of neurodegeneration resulting in the neuropathological and clinical manifestations of dementia. Functional brain imaging has elucidated the temporal sequence of amyloid deposition and glucose metabolic rate in the development of dementia in DS. Mitochondrial abnormalities contribute to oxidative stress which is part of AD pathogenesis in DS as well as AD in the general population. A variety of medical comorbidities threaten cognitive performance including sleep apnea, abnormalities in thyroid metabolism, and behavioral disturbances. Mouse models for DS are providing a platform for the formulation of clinical trials with intervention targeted to synaptic plasticity, brain biochemistry, and morphological brain alterations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One striking characteristic of people with DS is that at approximately 40–50 years of age, AD-like dementia often appears59,60.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is likely that both a dose effect of triplication of APP and gene-environment interactions play a role59,60.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The varied phenotypes of DS result from full or partial triplication of chromosome 21, the most common human chromosomal disorder59.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other proteins encoded on chromosome 21 may be involved59, such as Cu/Zn-superoxide dismutase (which is an important antioxidant enzyme normally, but can be deleterious if excess is present8) and Bach1 (transcriptional inhibitor of heme oxygenase-1, HO-1).”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Andriolo, R. B., Dib, R. E., Ramos, L., Atallah, Á. N., & da Silva, E. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005176.pub3 · Cited by 10
RetractedCerebellum and nonmotor function
Strick, P. L., Dum, R. P., & Fiez, J. A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125606 · Cited by 1,777 · cited 1×
“It seems plausible that neuropsychological abnormalities in DS such as impaired attention, executive control, language learning, working memory, and emotional responses may reflect dysfunction in the cerebellar–cortical–limbic circuitry (Strick et al., 2009).”
BackgroundSchmahmann, J. D. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.367 · Cited by 1,493 · cited 1×
“Beyond its effect on motor functioning, disorganized cerebellar output may impair higher order functioning such as emotion and cognition (Schmahmann, 2004; Teipel et al., 2004).”
BackgroundAmaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 2×
“…brain studies in autism have shown dysgenetic abnormalities in the frontal lobes, amygdala, and cerebellum—all areas that have been described as dysgenetic in DS. Recent reviews have suggested that the time course of brain development may be an important determining factor (Amaral et al., 2008).”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“The characteristic neuropathology of AD is present in the brains of individuals with DS by age 40 years (Mann and Esiri, 1989; Wisniewski et al., 1985).”
BackgroundThe pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812
Hearing loss and cognition in the Baltimore Longitudinal Study of Aging.
Lin, F. R., Ferrucci, L., Metter, E. J., An, Y., Zonderman, A. B., & Resnick, S. M. (2011) · Neuropsychology · doi:10.1037/a0024238 · Cited by 696 · cited 1×
“Hearing loss in adults in the general population may be independently associated with lower test scores of memory and executive functioning (Gates et al., 2010; Lin et al., 2011).”
BackgroundAmyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
Rumble, B. A., Retallack, R. W., Hilbich, C., Simms, G., Multhaup, G., Martins, R. N., Hockey, A., Montgomery, P., Beyreuther, K. T., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 656
Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · cited 1×
“In evaluation of the genes within the targeted chromosomal segment in Ts65Dn mice, it became apparent that an extra copy of the gene for APP contributed to decreased transport of nerve growth factor (Salehi et al., 2006).”
BackgroundCognitive deficits and associated neurological complications in individuals with Down's syndrome
Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484 · cited 2×
“As recently reviewed (Lott and Dierssen, 2010), the cerebellum may be implicated in both cognition and affect in individuals with DS.”
BackgroundSelf-citationMann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471 · cited 1×
“The characteristic neuropathology of AD is present in the brains of individuals with DS by age 40 years (Mann and Esiri, 1989; Wisniewski et al., 1985).”
BackgroundThe Effect of Chronic or Intermittent Hypoxia on Cognition in Childhood: A Review of the Evidence
Bass, J. L., Corwin, M. J., Gozal, D., Moore, C., Nishida, H., Parker, S. J., Schonwald, A., Wilker, R. E., Stehle, S., & Kinane, T. B. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0227 · Cited by 452 · cited 1×
“There have been few studies of the cognitive consequences of obstructive sleep apnea in DS, but there is known to be an association of sleep apnea with lower IQ testing and behavioral difficulties (Bass et al., 2004; Melendres et al., 2004).”
BackgroundNeuroanatomy of Down’s Syndrome: A High-Resolution MRI Study
Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1659 · Cited by 452 · cited 2×
“Magnetic resonance imaging (MRI) studies show an approximate 17% decrease in children with DS between 10 and 20years (Pinter et al., 2001a).”
BackgroundDevelopmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448 · cited 1×
“The Ts65Dn mouse model of DS appears to parallel the cholinergic degeneration found in adults with DS and dementia which is correlated with deficient release of acetylcholine from the hippocampus (Holtzman et al., 1996).”
BackgroundDaytime Sleepiness and Hyperactivity in Children With Suspected Sleep-Disordered Breathing
Melendres, C., Lutz, J. M., Rubin, E. D., & Marcus, C. L. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0730 · Cited by 381 · cited 1×
“There have been few studies of the cognitive consequences of obstructive sleep apnea in DS, but there is known to be an association of sleep apnea with lower IQ testing and behavioral difficulties (Bass et al., 2004; Melendres et al., 2004).”
BackgroundDown's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Baek, K., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I., Yoon, S. S., Minami, T., et al. (2009) · Nature · doi:10.1038/nature08062 · Cited by 375 · cited 1×
“However, other studies of subclinical hypothyroidism in the general population have failed to show significant neuropsychiatric problems (Baek et al., 2009).”
BackgroundCooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 1×
“Basal forebrain cholinergic neuronal degeneration has been reversed by intracerebroventricular injections of nerve growth factor (Cooper et al., 2001).”
BackgroundWisniewski, K. E. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370755 · Cited by 297 · cited 1×
“The brain is brachycephalic with a small cerebellum, simplified gyral appearance, and a narrow superior temporal gyrus (Coyle et al., 1986; Wisniewski, 1990).”
BackgroundSelective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates
Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., Gunning, F. M., McQuain, J., Driesen, N. R., & Acker, J. D. (1995) · Neurology · doi:10.1212/wnl.45.2.356 · Cited by 297 · cited 1×
“Ultrastructural studies show that synaptic density, synaptic length, and the contact zones between neurons are abnormal (Raz et al., 1995) (Fig.”
BackgroundCognitive profile and brain morphological changes in obstructive sleep apnea
Torelli, F., Moscufo, N., Garreffa, G., Placidi, F., Romigi, A., Zannino, S., Bozzali, M., Fasano, F., Giulietti, G., Djonlagic, I. E., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.065 · Cited by 296
Shott, S. R., Amin, R. S., Chini, B. A., Heubi, C. H., Hotze, S. L., & Akers, R. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.4.432 · Cited by 295 · cited 2×
“Obstructive sleep apnea occurs in over half of children with DS aged 2–4years and is related to otolaryngological problems associated with the disorder (Shott et al., 2006).”
BackgroundAlzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 290 · cited 2×
“Lack of balance in the metabolism of free radicals may have a direct role in the development of neuropathological changes of AD in DS (Zigman and Lott, 2007).”
BackgroundSelf-citationDYRK1A-mediated Hyperphosphorylation of Tau
Ryoo, S., Jeong, H. K., Radnaabazar, C., Yoo, J.-J., Cho, H.-J., Lee, H. W., Kim, I.-S., Cheon, Y. H., Ahn, Y. S., Chung, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707358200 · Cited by 285
Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., Bartesaghi, R., & Ciani, E. (2007) · Hippocampus · doi:10.1002/hipo.20308 · Cited by 281 · cited 2×
“An analysis of cell proteins expressed in various stages of the cell cycle has shown a prolongation of the G2 phase of the cell cycle, the last step in interphase prior to mitotic division (Contestabile et al., 2007).”
BackgroundMolecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278 · cited 2×
“…number of animals in a short time, genetic engineering for individual genes, control for genetic background, low cost of screening, ability to study both developing and mature subjects, modeling therapeutic interventions, and the lack of postmortem delays (Patterson, 2009; Salehi et al., 2007).”
BackgroundGuidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00113.x · Cited by 276 · cited 1×
“In fetuses with DS, an analysis of cell phenotypes shows less reduction in astrocytes as compared to neurons (Guidi et al., 2008).”
BackgroundNoebels, J. L. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02909.x · Cited by 261 · cited 1×
“Seizures in the temporal lobe may damage hippocampal circuitry, a situation which is worsened by the toxic accumulation of amyloid-b peptides seen in Alzheimer’s disease (AD) (Noebels, 2011).”
BackgroundMégarbané, A., Ravel, A., Mircher, C., Sturtz, F. G., Grattau, Y., Rethoré, M. O., Delabar, J. M., & Mobley, W. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2e34c · Cited by 261 · cited 1×
“This raises the prospect that treatment to reduce the level of APP gene expression may lessen the severity of cognitive decline in the dementia associated with DS (Megarbane et al., 2009).”
BackgroundPsychiatric and behavioral disorders in persons with Down syndrome
Dykens, E. M. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20159 · Cited by 258 · cited 2×
“age-matched peers, children with DS show higher rates of inattention, oppositional behaviors, and impulsivity (Dykens, 2007).”
BackgroundResultIntraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255 · cited 1×
“Memory loss in old age is strongly correlated with a decline in the levels of acetylcholine (Mori et al., 2002; White and Ruske, 2002).”
BackgroundIntrinsic defect of the immune system in children with Down syndrome: a review
Kusters, M., Verstegen, R. H. J., Gemen, E. F. A., & de Vries, E. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03890.x · Cited by 252 · cited 1×
“Immune dysfunction in DS has been associated with the occurrence of AD (Kusters et al., 2009).”
BackgroundThe neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248 · cited 1×
“The brain is brachycephalic with a small cerebellum, simplified gyral appearance, and a narrow superior temporal gyrus (Coyle et al., 1986; Wisniewski, 1990).”
BackgroundGene expression profiling in the adult Down syndrome brain
Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.005 · Cited by 240
Malformations of cortical development and epilepsy
Leventer, R. J., Guerrini, R., & Dobyns, W. B. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.1/rjleventer · Cited by 238
DiGuiseppi, C., Hepburn, S., Davis, J. M., Fidler, D. J., Hartway, S., Lee, N. R., Miller, L., Ruttenber, M., & Robinson, C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5aa6d · Cited by 233 · cited 1×
“…may reflect an underlying problem in social interactions in some children with DS. Recent use of screening tools and standardized diagnostic measures in 123 children with DS has yielded a prevalence of 18% for autistic spectrum disorders and 7% for the diagnosis of autism (DiGuiseppi et al., 2010).”
BackgroundGreen Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sebrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E. M., Gillet, B., Arbonés, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 227 · cited 1×
“In a study utilizing a polyphenol diet, the major features of the transgenic phenotype were rescued (Guedj et al., 2009).”
BackgroundImpaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness
White, N. S., & Alkire, M. T. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00103-4 · Cited by 223 · cited 1×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundMNB/DYRK1A as a multiple regulator of neuronal development
Tejedor, F. J., & Hämmerle, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07954.x · Cited by 214 · cited 1×
“Overexpression of DYRK1A may exert its effect on apoptosis and cell survival (Tejedor and Hammerle, 2011).”
BackgroundLeverenz, J. B., & Raskind, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6777 · Cited by 214 · cited 1×
“The parahippocampal and inferior temporal gyri demonstrate b-amyloid staining as young as 8years of age with subsequent accumulation in the CA-1/subiculum, dentate molecular layer, and the remainder of the hippocampal area (Leverenz and Raskind, 1998).”
BackgroundMartin, L. J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816ff780 · Cited by 213 · cited 3×
“DNA damage, repair, and abnormal dynamic flux have been linked to oxidative stress and AD-type neurodegeneration (Martin, 2008; Vasudevaraju et al., 2008).”
Background(1991) · PubMed · Cited by 209
Cognition and daytime functioning in sleep-related breathing disorders
Jackson, M. L., Howard, M. E., & Barnes, M. (2011) · Progress in Brain Research · doi:10.1016/b978-0-444-53817-8.00003-7 · Cited by 202 · cited 1×
“Findings here show impaired working memory, attention, vigilance, and the ability to carry out simulated activities in the face of obstructive sleep apnea (Jackson et al., 2011).”
Background(1990) · PubMed · Cited by 201
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200 · cited 1×
“The compound is also a noncompetitive inhibitor of the serotonin receptor 5HT3 (Rammes et al., 2001).”
BackgroundCognitive intervention in Alzheimer disease
Buschert, V. C., Bokde, A. L. W., & Hampel, H. J. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.113 · Cited by 197 · cited 1×
“Nonpharmacological interventions such as cognitive therapy and exercise have shown some improvements in individuals with AD within the general population (Buschert et al., 2010; Littbrand et al., 2011).”
BackgroundAmygdala and hippocampal volumes in children with Down syndrome: A high-resolution MRI study
Pinter, J. D., Brown, W. E., D, S. E. M., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · Neurology · doi:10.1212/wnl.56.7.972 · Cited by 197 · cited 2×
“Magnetic resonance imaging (MRI) studies show an approximate 17% decrease in children with DS between 10 and 20years (Pinter et al., 2001a).”
BackgroundDevelopment and validation of the Arizona Cognitive Test Battery for Down syndrome
Edgin, J. O., Mason, G. M., Allman, M. J., Capone, G. T., DeLeon, I. G., Maslen, C. L., Reeves, R. H., Sherman, S. L., & Nadel, L. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9054-3 · Cited by 194 · cited 2×
“Cognitive development in DS has been described elsewhere in this volume (Edgin et al., 2010a).”
BackgroundHealth Conditions Associated with Aging and End of Life of Adults with Down Syndrome
Esbensen, A. J. (2010) · International review of research in mental retardation · doi:10.1016/s0074-7750(10)39004-5 · Cited by 186 · cited 3×
“Individuals with DS are prone to develop hyperopia, strabismus, blepharitis, cataracts, and glaucoma (Esbensen, 2010; van Allen et al., 1999).”
BackgroundDown syndrome, Alzheimer’s disease and seizures
Menéndez, M. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.07.008 · Cited by 186 · cited 1×
“Individuals with DS over age 45 years are more likely to develop dementia than those with seizures onset at younger ages (Menendez, 2005).”
BackgroundSimms, M. L., Kemper, T. L., Timbie, C. M., Bauman, M. L., & Blatt, G. J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0568-2 · Cited by 183 · cited 2×
“Moreover, careful morphological studies of postmortem brain of individuals with autism have shown subgroup variability in neuronal density, providing a cytoarchitectonic foundation for brain heterogeneity (Simms et al., 2009).”
BackgroundBrain Plasticity and Disease: A Matter of Inhibition
Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Maffei, L., & Sale, A. (2011) · Neural Plasticity · doi:10.1155/2011/286073 · Cited by 173 · cited 1×
“Cortical-inhibition circuitries regulating neural plasticity has been postulated as related to the pathogenesis of brain functioning in both DS and autistic disorder (Baroncelli et al., 2011).”
BackgroundSeizure Disorders in Down Syndrome
Pueschel, S. M., Louis, S., & McKnight, P. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150088024 · Cited by 172 · cited 1×
“The occurrence is bimodal with 40% having seizures before 1year of age—generally infantile spasms—and with 40% developing seizures after the third decade, generally tonic–clonic or myoclonic in manifestation (Pueschel et al., 1991).”
BackgroundBraudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., de Chaumont, F., Olivo‐Marín, J., Dodd, R. H., Hérault, Y., & Potier, M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405366 · Cited by 172 · cited 1×
“Development of a GABA-A benzodiazepine receptor inverse agonist that is selective for the a5-subtype receptor appears to eliminate the convulsant propensity while maintaining cognitive restorative properties (Braudeau et al., 2011a,b).”
BackgroundGuidi, S., Ciani, E., Bonasoni, P., Santini, D., & Bartesaghi, R. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00459.x · Cited by 165 · cited 1×
“The anatomic locus for hypotonia in DS appears to be the cerebellum, a structure which shows hypocellularity due to impairment in the granular and periventricular zones during fetal development (Guidi et al., 2011).”
BackgroundStores, R., Stores, G., FELLOWS, B. J., & Buckley, S. (1998) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1998.00123.x · Cited by 162 · cited 1×
“Children with DS may be at a lower risk for significant behavioral comorbidities in that they show a lower profile of maladaptive behaviors compared to children with other intellectual disabilities (Dykens and Kasari, 1997; Stores et al., 1998).”
BackgroundCoskun, P. E., Wyrembak, J., Derbereva, O., Melkonian, G., Doran, E. W., Lott, I. T., Head, E., Cotman, C. W., & Wallace, D. C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100351 · Cited by 161 · cited 1×
“Mitochondrial control region mutations are seen in the brains of individuals with DS and dementia as well as AD (Coskun et al., 2010) (Fig.”
BackgroundSelf-citationEvidence for a Specific Defect in Hippocampal Memory in Overt and Subclinical Hypothyroidism
Correia, N., Mullally, S. L., Cooke, G. E., Tun, T. K., Phelan, N., Feeney, J. C., Fitzgibbon, M. C., Boran, G. P., O’Mara, S. M., & Gibney, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2702 · Cited by 159 · cited 1×
“The impairments resulting from hypothyroidism are primarily mnemonic rather than a reflection of general cognitive slowing and suggest a disruption of normal hippocampal function or connectivity (Correia et al., 2009).”
BackgroundFocal cortical dysplasia type II: biological features and clinical perspectives
Sisodiya, S. M., Fauser, S., Cross, J. H., & Thom, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70201-7 · Cited by 155 · cited 2×
“…to the areas of brain dysgenesis that are commonly part of the neuroanatomic presentation in DS. Areas of focal cortical dysplasia may be associated with epilepsy in the general population related to the location and size of the lesions (Andrade, 2009; Leventer et al., 2008; Sisodiya et al., 2009).”
BackgroundTeipel, S. J., Alexander, G. E., Schapiro, M. B., Möller, H., Rapoport, S. I., & Hampel, H. J. (2004) · Brain · doi:10.1093/brain/awh101 · Cited by 154 · cited 2×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundWhy Pleiotropic Interventions are Needed for Alzheimer's Disease
Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 152 · cited 1×
“The challenge of therapeutic trials in DS is similar to those reviewed for AD in the general population for which pleiotropic interventions have been recommended (Frautschy and Cole, 2010).”
BackgroundMarvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 150 · cited 1×
“Memantine is an antagonist of N-methyl D-aspartate receptor and appears to exert a positive effect on cognitive function by reducing oxidative damage and upregulating brain-derived neurotrophic factor (Marvanova et al., 2001).”
BackgroundLittbrand, H., Stenvall, M., & Rosendahl, E. (2011) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318214de26 · Cited by 147 · cited 1×
“Nonpharmacological interventions such as cognitive therapy and exercise have shown some improvements in individuals with AD within the general population (Buschert et al., 2010; Littbrand et al., 2011).”
BackgroundKesslak, J. P., Nagata, S. F., Lott, I., & Nalcioglu, O. (1994) · Neurology · doi:10.1212/wnl.44.6.1039 · Cited by 145 · cited 1×
“Unexplainably, the parahippocampal gyrus may be larger than normal in DS (Kesslak et al., 1994).”
BackgroundSelf-citationEpilepsy in children with Down syndrome
Arya, R., Kabra, M., & Gulati, S. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0415 · Cited by 144 · cited 2×
“It appears that children with DS have better seizure control compared to other patients with symptomatic infantile spasms, and early initiation of appropriate treatment may contribute to the prevention of late seizure development and better developmental outcome (Arya et al., 2011).”
BackgroundExecutive Dysfunction and Presbycusis in Older Persons With and Without Memory Loss and Dementia
Gates, G. A., Gibbons, L. E., McCurry, S. M., Crane, P. K., Feeney, M. P., & Larson, E. B. (2010) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181d748d7 · Cited by 143 · cited 1×
“Hearing loss in adults in the general population may be independently associated with lower test scores of memory and executive functioning (Gates et al., 2010; Lin et al., 2011).”
BackgroundResearch Review: Reading comprehension in developmental disorders of language and communication
Ricketts, J. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02438.x · Cited by 142 · cited 1×
“Difficulties in word recognition, oral language, nonverbal ability, and working memory may underline reading comprehension problems in both DS and autistic spectrum disorders (Ricketts, 2011).”
BackgroundAutism, Alzheimer disease, and fragile X
Sokol, D. K., Maloney, B., Long, J. M., Ray, B., & Lahiri, D. K. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166dc7 · Cited by 141 · cited 1×
“Treatment with glutamate receptor antagonists may help repress APP and serve as a therapeutic target for AD (Sokol et al., 2011).”
BackgroundGonzález‐Agüero, A., Vicente‐Rodríguez, G., Moreno, L. A., Guerra-Balic, M., Ara, I., & Casajús, J. A. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2010.01120.x · Cited by 134 · cited 1×
“The low levels of physical activity in DS result in a higher body mass index, lower levels of lean mass, and reduced bone mass-related parameters, which, in turn, may affect cardiovascular strength capacities (Gonzalez-Aguero et al., 2010).”
BackgroundAmyloid-β Toxicity and Tau Hyperphosphorylation are Linked Via RCAN1 in Alzheimer's Disease
Lloret, A., Badía, M.-C., Giraldo, E., Ermak, G., Alonso, M.-D., Pallardó, F. V., Davies, K. J. A., & Viña, J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110890 · Cited by 133 · cited 1×
“Oxidative stress may be a common pathogenetic mechanism across multiple genetic disorders including ataxia-telangiectasia, Fanconi anemia, Werner syndrome, and DS (Lloret et al., 2011).”
BackgroundMENTAL AND MOTOR DEVELOPMENT IN YOUNG MONGOL CHILDREN*
Carr, J. (1970) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1970.tb01116.x · Cited by 133 · cited 2×
“from hypotonia is associated with a delay in motor development (Carr, 1970; Melyn and White, 1973).”
BackgroundValenti, D., Manente, G. A., Moro, L., Marra, E., & Vacca, R. A. (2011) · Biochemical Journal · doi:10.1042/bj20101908 · Cited by 133 · cited 1×
“A complex I deficit has been described in mitochondria from skin fibroblasts in DS that produces free radicals associated with oxidative stress (Valenti et al., 2011).”
BackgroundInfantino, V., Castegna, A., Iacobazzi, F., Spera, I., Scala, I., Andria, G., & Iacobazzi, V. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.166 · Cited by 133 · cited 1×
“Methylation, which is a necessary event in mitochondrial functioning, is impaired in DS (Infantino et al., 2011).”
BackgroundPostural control in children, teenagers and adults with Down syndrome
Rigoldi, C., Galli, M., Mainardi, L. T., Crivellini, M., & Albertini, G. (2010) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2010.09.007 · Cited by 131 · cited 1×
“The hypotonia induces difficulty in postural control such that an individual with DS is focused on overcoming a lack of equilibrium compared to controls and this necessitates a different strategy in motor development (Rigoldi et al., 2011).”
BackgroundDown syndrome and beta-amyloid deposition
Head, E., & Lott, I. T. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00003 · Cited by 129 · cited 2×
“Other genes on chromosome 21 that have been implicated in the pathogenesis of AD include superoxide dismutase, Ets-2 transcription factors, DS critical region stress-inducible factor, b-site APP cleaving enzyme, and S100b and dual-specificity tyrosine phosphorylation-regulation kinase 1A (DYRK1A) (Head and Lott, 2004).”
BackgroundSelf-citationDrug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127 · cited 1×
“An ongoing conundrum for the use of agents to improve cognitive functioning is the interaction of the drug with existing medication, an issue that has been explored in the neuropsychiatric literature and which can be addressed partially through preclinical studies (Wallace et al., 2011).”
BackgroundEdgin, J. O., Pennington, B. F., & Mervis, C. Β. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01278.x · Cited by 122 · cited 2×
“Cognitive development in DS has been described elsewhere in this volume (Edgin et al., 2010a).”
BackgroundStrengthening Behavioral Research on Genetic Mental Retardation Syndromes
Hodapp, R. M., & Dykens, E. M. (2001) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2001)106 · Cited by 121
Profiles and development of adaptive behavior in children with Down syndrome
Dykens, E. M., Hodapp, R. M., & Evans, D. W. (2006) · Down Syndrome Research and Practice · doi:10.3104/reprints.293 · Cited by 120 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundPritchard, M. A., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_20 · Cited by 118 · cited 1×
“This may be an example of the disruption of developmental timing and homeostasis that occurs in DS and possibly other examples of aneuploidy (Pritchard and Kola, 1999).”
BackgroundCleland, J., Wood, S. E., Hardcastle, W. J., Wishart, J. G., & Timmins, C. (2009) · International Journal of Language & Communication Disorders · doi:10.3109/13682820902745453 · Cited by 116 · cited 1×
“Cleland (Cleland et al., 2010) has challenged the stereotypical perception that individuals with DS are highly social and have excellent “people” skills.”
BackgroundShields, N., & Taylor, N. F. (2010) · Journal of physiotherapy · doi:10.1016/s1836-9553(10)70024-2 · Cited by 116 · cited 2×
“…aspects from strategies using mixed physical activity programs, well-conducted research examining long-term physical outcomes, adverse effects, psychosocial outcomes, and costs is required before informed practice decisions can be made (Andriolo et al., 2010; Shields and Taylor, 2010).”
BackgroundEndocrine and musculoskeletal abnormalities in patients with Down syndrome
Hawli, Y. M. A., Nasrallah, M., & Fuleihan, G. E. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.80 · Cited by 115 · cited 1×
“Hypotonia in DS is often associated with low levels of physical activity with the result of decreased bone mass accrual and predisposition to fractures (Hawli et al., 2009).”
BackgroundRelation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down’s Syndrome
Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J., Horwitz, B., Hoehne, C., Möller, H., Rapoport, S. I., & Hampel, H. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1870 · Cited by 113 · cited 1×
“These anatomic findings have also been seen by voxel-based morphometric MRI studies of the brain in children and adults with DS (Pinter et al., 2001a,b; Teipel et al., 2003, 2004; White and Alkire, 2003).”
BackgroundLewis, J. D., & Elman, J. L. (2007) · Developmental Science · doi:10.1111/j.1467-7687.2007.00634.x · Cited by 109 · cited 1×
“Put slightly differently, deviant growth trajectories in autism may lead to developmental disruption of established patterns of functional connectivity (Lewis and Elman, 2008).”
BackgroundEmotional Competence in Children With Down Syndrome: Negativity and Regulation
Jahromi, L. B., Gulsrud, A. C., & Kasari, C. L. (2008) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2008)113[32:ecicwd]2.0.co;2 · Cited by 104 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundThe use of mouse models to understand and improve cognitive deficits in Down syndrome
Das, I., & Reeves, R. H. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007716 · Cited by 103 · cited 4×
“There are many genes in the mouse that are orthologous to genes on human chromosome 21 (Das and Reeves, 2011).”
BackgroundInfluentialDierssen, M., & de Lagrán, M. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.319 · Cited by 97
Molecular changes in fetal Down syndrome brain
Engidawork, E., & Lübec, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01614.x · Cited by 96 · cited 1×
“This reduction in brain size appears in 4–5-month fetuses and progresses during the last 3months of gestation (Engidawork and Lubec, 2003; Guihard-Costa et al., 2006).”
BackgroundThe development of learning difliculties in children with Down's syndrome
Wishart, J. G. (1993) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1993.tb00882.x · Cited by 96 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundDown Syndrome and Dementia: Seizures and Cognitive Decline
Lott, I. T., Doran, E. W., Nguyen, V. Q., Tournay, A. E., Movsesyan, N., & Gillen, D. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111613 · Cited by 95 · cited 1×
“Seizures appear to be associated with rapid cognitive decline in demented individuals with DS (Lott et al., 2012).”
BackgroundSelf-citationPrevalence of Pervasive Developmental Disorder in Down’s Syndrome
Lowenthal, R., Paula, C. S., Schwartzman, J. S., Brunoni, D., & Mercadante, M. T. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0374-4 · Cited by 94 · cited 1×
“This is over a 10-fold increase compared to the general population (Lowenthal et al., 2007).”
BackgroundDepression in Down Syndrome: A review of the literature
Walker, J. C., Došen, A., Buitelaar, J. K., & Janzing, J. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.02.010 · Cited by 94 · cited 1×
“While it has been thought that individuals with DS are more prone to depression than those with other forms of intellectual disability, a recent meta-review does not support the putative increased prevalence of depression in trisomy 21 (Walker et al., 2011).”
BackgroundMENTAL AND DEVELOPMENTAL MILESTONES OF NONINSTITUTIONALIZED DOWN'S SYNDROME CHILDREN
Melyn, M. A., & White, D. T. (1973) · PEDIATRICS · doi:10.1542/peds.52.4.542 · Cited by 93 · cited 1×
“The ligamentous laxity resulting from hypotonia is associated with a delay in motor development (Carr, 1970; Melyn and White, 1973).”
BackgroundKim, S.-J., Lee, J. H., Lee, D. Y., Jhoo, J. H., & Woo, J. I. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e9b976 · Cited by 93 · cited 1×
“In patients with mild cognitive impairment in the general population, sleep apnea was associated with an increase in language dysfunction (Kim et al., 2011).”
BackgroundHead, E., Lott, I. T., Patterson, D. W., Doran, E. W., & Haier, R. J. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11110 · Cited by 91 · cited 1×
“Neurite sprouting has been seen in approximately the same areas by postmortem examination (Haier et al., 2003; Head et al., 2007).”
BackgroundSelf-citationLu, J., Esposito, G., Scuderi, C., Steardo, L., Delli-Bovi, L. C., Hecht, J. L., Dickinson, B. C., Chang, C. J., Mori, T., & Sheen, V. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022126 · Cited by 91 · cited 1×
“Dysregulated chromosome 21 genes in cortical neural progenitor cells from individuals with DS lead to elevated levels of S100b-induced radical oxygen species along with loss of the water channel aquaporin 4, causing an increase in programmed cell death (Lu et al., 2011).”
BackgroundSystemic and neurologic autoimmune disorders associated with seizures or epilepsy
Vincent, A. C., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03030.x · Cited by 87 · cited 1×
“Histopathological brain lesions include gliosis, demyelination, spongiform transformation of neurons, and vasculitis involving venules (Vincent and Crino, 2011).”
BackgroundNon‐psychiatric health problems among psychiatric inpatients with intellectual disabilities
Charlot, L., Abend, S. L., Ravin, P., Mastis, K., Hunt, A., & Deutsch, C. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01294.x · Cited by 86 · cited 1×
“In a study of nonpsychiatric health factors leading to psychiatric decompensation in adults with DS, 40% were found to have a significant comorbid medical condition considered causal in the behavioral decline (Charlot et al., 2011).”
BackgroundBiometry of Face and Brain in Fetuses with Trisomy 21
Guihard-Costa, A.-M., Khung‐Savatovsky, S., Delbecque, K., Ménez, F., & Delezoide, A. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000190580.88391.9a · Cited by 85 · cited 1×
“This reduction in brain size appears in 4–5-month fetuses and progresses during the last 3months of gestation (Engidawork and Lubec, 2003; Guihard-Costa et al., 2006).”
BackgroundDonepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17
Kishnani, P. S., Heller, J. H., Spiridigliozzi, G. A., Lott, I. T., Escobar, L., Richardson, S., Zhang, R. H., & McRae, T. D. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33730 · Cited by 83 · cited 1×
“Likewise, a trial of donepezil in children and adolescents with DS failed to demonstrate cognitive benefit (Kishnani et al., 2010).”
BackgroundSelf-citationChange in plasma Aβ peptides and onset of dementia in adults with Down syndrome
Schupf, N., Zigman, W. B., Tang, M. X., Pang, D. I., Mayeux, R. P., Mehta, P. D., & Silverman, W. P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb448b · Cited by 81 · cited 2×
“indicators of conversion to AD, possibly reflecting compartmentalization of b-amyloid peptides in the brain (Schupf et al., 2010).”
BackgroundInfluentialTsao, R., & Kindelberger, C. (2008) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2008.10.009 · Cited by 79 · cited 1×
“The precise effect of the above-described cytoarchitectonic abnormalities on cognitive development in DS is not clear, in part due to individual variation in performance measures with age (Couzens et al., 2011; Tsao and Kindelberger, 2009).”
BackgroundCognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB)
Ανδρέου, Γ., Galanopoulou, C., Gourgoulianis, K., Karapetsas, A. B., & Molyvdas, P. A. (2002) · Brain and Cognition · doi:10.1016/s0278-2626(02)00019-2 · Cited by 79 · cited 1×
“In a small study of children with DS, sleep apnea was associated with difficulties in visual-perceptual skills involving the right hemisphere (Andreou et al., 2002).”
BackgroundHead, E., Doran, E. W., Nistor, M., HILL, M., Schmitt, F. A., Haier, R. J., & Lott, I. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101335 · Cited by 75 · cited 1×
“After controlling for level of intellectual disability (mild, moderate, severe) and the presence or absence of dementia, there was an improved prediction of neuropsychological scores by plasma levels of b-amyloid (Head et al., 2011).”
BackgroundSelf-citationÇeti̇ner, S., Demırhan, O., İnal, T. C., Korkmaz, D. T., & Sertdemır, Y. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00914.x · Cited by 75 · cited 1×
“The immune dysfunction begins in children with DS as reflected in abnormalities seen on the analysis of peripheral T-cell subsets, natural killer cells, and serum cytokines (Cetiner et al., 2010).”
BackgroundCouzens, D., Cuskelly, M., & Haynes, M. A. (2011) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-116.3.181 · Cited by 72 · cited 1×
“The precise effect of the above-described cytoarchitectonic abnormalities on cognitive development in DS is not clear, in part due to individual variation in performance measures with age (Couzens et al., 2011; Tsao and Kindelberger, 2009).”
BackgroundPositron Emission Tomography of Brain β-Amyloid and Tau Levels in Adults With Down Syndrome
Nelson, L. D., Siddarth, P., Kepe, V., Scheibel, K. E., Huang, S. C., Barrio, J. R., & Small, G. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.104 · Cited by 72 · cited 1×
“Measures of behavioral dysfunction in the same study are consistent with age-related progression of AD neuropathology in this population (Nelson et al., 2011).”
ResultTemporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier, R. J., Alkire, M. T., White, N. S., Uncapher, M. R., Head, E., Lott, I. T., & Cotman, C. W. (2003) · Neurology · doi:10.1212/01.wnl.0000098935.36984.25 · Cited by 71 · cited 1×
“Neurite sprouting has been seen in approximately the same areas by postmortem examination (Haier et al., 2003; Head et al., 2007).”
BackgroundSelf-citationUsing mouse models to explore genotype–phenotype relationship in Down syndrome
Salehi, A., Faizi, M., Belichenko, P. V., & Mobley, W. C. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20164 · Cited by 70 · cited 2×
“…number of animals in a short time, genetic engineering for individual genes, control for genetic background, low cost of screening, ability to study both developing and mature subjects, modeling therapeutic interventions, and the lack of postmortem delays (Patterson, 2009; Salehi et al., 2007).”
BackgroundNeuropsychological correlates of word identification in Down syndrome
Fidler, D. J., Most, D. E., & Guiberson, M. (2005) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2004.11.007 · Cited by 70 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundMerrick, J., Ezra, E., Josef, B., Hendel, D., Steinberg, D. M., & Wientroub, S. (2000) · Journal of Pediatric Orthopaedics B · doi:10.1097/01202412-200006000-00008 · Cited by 69 · cited 1×
“In individuals with DS, the excessive laxity of the posterior transverse ligament which attaches the odontoid bone to C1 appears to be the most common cause of atlanto-axial subluxation although there is no universal agreement on this point (Merrick et al., 2000).”
BackgroundMemory deficits in Alzheimer's disease: The encoding hypothesis and cholinergic function
White, K. G., & Ruske, A. C. (2002) · Psychonomic Bulletin & Review · doi:10.3758/bf03196301 · Cited by 69 · cited 1×
“Memory loss in old age is strongly correlated with a decline in the levels of acetylcholine (Mori et al., 2002; White and Ruske, 2002).”
BackgroundSimone, R. D., Salas‐Puig, X., Gélisse, P., Crespel, A., & Genton, P. (2010) · Seizure · doi:10.1016/j.seizure.2010.04.008 · Cited by 69 · cited 1×
“Senile myoclonic epilepsy appears to be a common manifestation of dementia in DS (De Simone et al., 2010).”
BackgroundAndriolo, R. B., Dib, R. E., Ramos, L., Atallah, Á. N., & da Silva, E. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005176.pub4 · Cited by 68 · cited 1×
“…aspects from strategies using mixed physical activity programs, well-conducted research examining long-term physical outcomes, adverse effects, psychosocial outcomes, and costs is required before informed practice decisions can be made (Andriolo et al., 2010; Shields and Taylor, 2010).”
BackgroundTreated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study
Kramer, C. K., von Mühlen, D. G., Kritz‐Silverstein, D. C., & Barrett-Connor, E. L. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0606 · Cited by 68 · cited 1×
“In subclinical and overt hypothyroidism in the general population, deficits are noted in spatial, associative, and verbal memory with some amelioration by thyroid replacement therapy (Kramer et al., 2009).”
BackgroundLandt, J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.36 · Cited by 65 · cited 1×
“4b) (Landt et al., 2011).”
Oxidative stress and cognitive ability in adults with Down syndrome
Strydom, A., Dickinson, M. J., Shende, S., Praticò, D., & Walker, Z. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.006 · Cited by 62 · cited 1×
“Multiple genes that are upregulated in trisomy 21 may contribute to transcriptional disruption and increase the liability to oxidative stress (Lockstone et al., 2007; Strydom et al., 2009).”
BackgroundEvaluation of memantine for the treatment of Alzheimer?s disease
Ferris, S. H. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.12.2305 · Cited by 60 · cited 1×
“In the general population, the drug appears to alleviate some symptoms of AD (Ferris, 2003).”
BackgroundBraudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R. H., Hérault, Y., Delatour, B., & Potier, M. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/153218 · Cited by 60 · cited 1×
“Development of a GABA-A benzodiazepine receptor inverse agonist that is selective for the a5-subtype receptor appears to eliminate the convulsant propensity while maintaining cognitive restorative properties (Braudeau et al., 2011a,b).”
BackgroundAndrade, D. M. (2009) · Human Genetics · doi:10.1007/s00439-009-0702-1 · Cited by 59 · cited 2×
“…to the areas of brain dysgenesis that are commonly part of the neuroanatomic presentation in DS. Areas of focal cortical dysplasia may be associated with epilepsy in the general population related to the location and size of the lesions (Andrade, 2009; Leventer et al., 2008; Sisodiya et al., 2009).”
BackgroundPatel, A., Rees, S. D., Kelly, M. A., Bain, S. C., Barnett, A. H., Thalitaya, D., & Prasher, V. P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.010 · Cited by 59 · cited 1×
“There is an association of several biomarkers for AD for in the general population that are also seen in individuals with DS including APOE, SORL1, RUNX1, BACE1, and ALDH18a1 (Patel et al., 2011).”
BackgroundAlzheimer's Disease and Down Syndrome Rodent Models Exhibit Audiogenic Seizures
Westmark, C. J., Westmark, P. R., & Malter, J. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100087 · Cited by 58 · cited 1×
“These findings suggest that the amyloid precursor protein (APP), which is overexpressed in DS, may mediate this seizure susceptibility through the glutamate receptor (Westmark et al., 2009, 2010).”
BackgroundMolecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs
Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7359 · Cited by 58 · cited 1×
“Molecular dating techniques have shown that b-amyloid is deposited in the superficial layers of the frontal cortex in DS with subsequent transition to deeper cortical areas with age (Azizeh et al., 2000).”
Self-citationTrainee teachers’ attitudes to inclusive education for children with Down's syndrome
Wishart, J. G., & Manning, G. (1996) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1996.tb00603.x · Cited by 57 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundEngineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
Toiber, D., Azkona, G., Ben‐Ari, S., Torán, N., Soreq, H., & Dierssen, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.011 · Cited by 55 · cited 1×
“Individuals with DS and mice with partial trisomy contain an extra copy of the DYRK1A gene and this appears to be associated with changes in brain morphogenesis (Dierssen and de Lagran, 2006; Toiber et al., 2010).”
BackgroundDonepezil for dementia in people with Down syndrome
Mohan, M., Carpenter, P. K., & Bennett, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007178.pub2 · Cited by 54 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundMemory Profiles of Down, Williams, and Fragile X Syndromes: Implications for Reading Development
Conners, F. A., Moore, M. S., Loveall, S. J., & Merrill, E. C. (2011) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3182168f95 · Cited by 53 · cited 1×
“Children with DS appear to present memory profiles that are distinct from other Williams and fragile-X syndromes in that DS is characterized by good immediate visual memory and rapid phonological retrieval with poor verbal working memory skills (Conners et al., 2011; Edgin et al., 2010b).”
BackgroundEconomy and Preferred Speed of Walking in Adults with and Without Down Syndrome
Agiovlasitis, S., McCubbin, J. A., Yun, J., Pavol, M. J., & Widrick, J. J. (2009) · Adapted Physical Activity Quarterly · doi:10.1123/apaq.26.2.118 · Cited by 53 · cited 2×
“Infants with DS show a sequence of motor development similar to typically developing toddlers but a lower rate of motor milestone acquisition (Agiovlasitis et al., 2009).”
BackgroundHashimoto’s Thyroiditis in Down’s Syndrome: Clinical Presentation and Evolution
Popova, G., Paterson, W. F., Brown, A., & Donaldson, M. (2008) · Hormone Research in Paediatrics · doi:10.1159/000157874 · Cited by 49 · cited 1×
“Hashimoto’s encephalopathy, an autoimmune complication of hypothyroidism, which presents with myoclonus, neuropsychiatric symptoms, cognitive decline, and stroke-like episodes, has been described in DS (Brodtmann, 2009; Popova et al., 2008).”
BackgroundClinical and EEG Features of Epilepsy in Children and Adolescents in Down Syndrome
Śmigielska–Kuzia, J., Sobaniec, W., Kułąk, W., & Boćkowski, L. (2009) · Journal of Child Neurology · doi:10.1177/0883073808324542 · Cited by 48 · cited 1×
“There is a high rate of EEG abnormalities in DS without the recognition of clinical seizures (40%); therefore, EEG findings do not correlate with outcome (Smigielska-Kuzia et al., 2009).”
BackgroundChang, Q., & Gold, P. E. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.05.007 · Cited by 47 · cited 1×
“An encouraging aspect of the mouse study was the reversal of deficits in the 4-month-old Ts65Dn mouse when treated with an acetylcholinesterase inhibitor (Chang and Gold, 2008).”
BackgroundLennox‐Gastaut syndrome with late‐onset and prominent reflex seizures in trisomy 21 patients
Ferlazzo, E., Adjien, C. K., Guerrini, R., Calarese, T., Crespel, A., Elia, M., Striano, P., Gélisse, P., Bramanti, P., Bella, P. D., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01944.x · Cited by 47 · cited 1×
“When Lennox–Gastaut syndrome occurs in DS, the onset is usually later than seen in the typical population and may be associated with reflex seizures (Ferlazzo et al., 2009).”
BackgroundMemantine for dementia in people with Down syndrome.
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007657 · Cited by 46 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundCosta, A. C. S. (2011) · Developmental Neuroscience · doi:10.1159/000330861 · Cited by 44 · cited 1×
“These findings have been translated into a clinical trial of memantine for improving cognitive functioning in young adults with DS which is currently underway (Costa, 2011).”
BackgroundRivastigmine for dementia in people with Down syndrome
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007658 · Cited by 43 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundRueda, N., Flórez, J., & Martínez‐Cué, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.020 · Cited by 42 · cited 1×
“In the Ts65Dn mouse, oral treatment with memantine improved spatial learning in the Morris water maze task (Rueda et al., 2008).”
MethodGalantamine for dementia in people with Down syndrome
Mohan, M., Bennett, C., & Carpenter, P. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007656 · Cited by 40 · cited 1×
“However, in DS, there appears to be no consistent or compelling evidence for efficacy of acetylcholinesterase inhibitors including donepezil, galantamine, and rivastigmine in preventing the cognitive decline associated with dementia (Mohan et al., 2009a–d).”
BackgroundDoes nicotine improve cognitive function?
Rusted, J. M., Graupner, L., O'Connell, N., & Nicholls, C. (1994) · Psychopharmacology · doi:10.1007/bf02245580 · Cited by 39 · cited 1×
“Administration of drugs that inhibit the breakdown of acetylcholine (donepezil) has reversed the memory deficits associated with aging and AD in the general population (Rusted et al., 1994; van Reekum et al., 1997).”
BackgroundRole of DNA dynamics in Alzheimer's disease
Vasudevaraju, P., ..., B., Garruto, R. M., Sambamurti, K., & Rao, K. S. J. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.01.001 · Cited by 37 · cited 2×
“DNA damage, repair, and abnormal dynamic flux have been linked to oxidative stress and AD-type neurodegeneration (Martin, 2008; Vasudevaraju et al., 2008).”
BackgroundMastery motivation in children with Down syndrome
Glenn, S. M., Dayus, B., Cunningham, C., & Horgan, M. F. (2001) · Down Syndrome Research and Practice · doi:10.3104/reports.114 · Cited by 37 · cited 1×
“Differences are cited in developing task-oriented strategies for problem solving and difficulties with goaldirected behaviors (Glenn et al., 2001; Jahromi et al., 2008; Kasari and Freeman, 2001; Wishart, 1993; Wishart and Manning, 1996).”
BackgroundUrinary uric acid and antioxidant capacity in children and adults with Down syndrome
Campos, C., Guzmán, R., López-Fernández, E., & Casado, Á. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.09.017 · Cited by 36 · cited 1×
“Urinary markers of oxidative stress are increased in adolescents and adults with DS (Campos et al., 2010).”
BackgroundAmyloid β concentrations in older people with Down syndrome and dementia
Jones, E. L., Hanney, M., Francis, P. T., & Ballard, C. G. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.12.030 · Cited by 35 · cited 4×
“However, in demented adults with DS, APOE4 allele was associated with higher Ab40 but not Ab42.”
BackgroundInfluentialRecognition and management of childhood cancer syndromes: A systems approach
Clericuzio, C. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990625)89:2 · Cited by 34
Specific grasp characteristics of children with trisomy 21
Jover, M., Ayoun, C., Berton, C., & Carlier, M. (2010) · Developmental Psychobiology · doi:10.1002/dev.20474 · Cited by 34 · cited 1×
“The instability in trunk control may be linked to atypical finger grasping patterns (Jover et al., 2010).”
BackgroundUse of health care guidelines in patients with Down syndrome by family physicians across Canada
Virji‐Babul, N., Eichmann, A., Kisly, D., Down, J., & Haslam, R. H. A. (2007) · Paediatrics & Child Health · doi:10.1093/pch/12.3.179 · Cited by 30 · cited 2×
“Evaluation of thyroid functioning has been a part of health care guidelines for both children and adults with DS (Virji-Babul et al., 2007).”
BackgroundCognition-enhancing drugs in dementia: a guide to the near future.
van Reekum, R., Black, S. E., Conn, D. K., & Clarke, D. E. (1997) · PubMed · Cited by 30
Epilepsy in adult patients with Down syndrome: a clinical‐video EEG study
Vignoli, A., Zambrelli, E., Chiesa, V., Savini, M. N., Briola, F. L., Gardella, E., & Canevini, M. P. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0426 · Cited by 30 · cited 2×
“Electroclinical characteristics of seizures in adults with DS have included progressive slowing of background activity with frontal sharp and slow waves while those with myoclonic epilepsy typically display generalized spike and slow wave discharges (Vignoli et al., 2011).”
BackgroundMPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.
Westmark, C. J., Westmark, P. R., & Malter, J. S. (2009) · PubMed Central · Cited by 29
Adaptive behaviour in Down syndrome: a cross-sectional study from childhood to adulthood
Dressler, A., Perelli, V., Feucht, M., & Bargagna, S. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1504-0 · Cited by 28 · cited 1×
“Socialization and competence in daily living skills appear to improve through age 30years in DS (Dressler et al., 2010).”
BackgroundMelatonin and Elimination of Kynurenines in Children with Down's Syndrome
Uberos, J., Romero, J. L. C., Molina‐Carballo, A., & Muñoz‐Hoyos, A. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.3.277 · Cited by 26
Hashimoto Encephalopathy and Down Syndrome
Brodtmann, A. G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.45 · Cited by 26 · cited 1×
“Hashimoto’s encephalopathy, an autoimmune complication of hypothyroidism, which presents with myoclonus, neuropsychiatric symptoms, cognitive decline, and stroke-like episodes, has been described in DS (Brodtmann, 2009; Popova et al., 2008).”
Backgroundβ-Amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome
Head, E., Lott, I. T., Cribbs, D. H., Cotman, C. W., & Rohn, T. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00705-x · Cited by 23 · cited 1×
“Caspase activation, another precursor of programmed cell death, occurs in association with amyloid plaques and neurofibrillary tangles in DS (Head et al., 2002).”
BackgroundSelf-citationGalli, M., Cimolin, V., Patti, P. J., Ferrario, D., Heaney, G., Albertini, G., & Freedland, R. L. (2010) · Disability and Rehabilitation · doi:10.3109/09638281003734367 · Cited by 23 · cited 1×
“In a quantitative movement protocol measuring functional mobility, individuals with DS appeared to show longer durations of execution across all of the standardized tasks (Galli et al., 2010).”
BackgroundInfantile spasms in children with Down syndrome.
Lujić, L., Bošnjak, V. M., Delin, S., Đuranović, V., & Krakar, G. (2011) · PubMed · Cited by 22
The effect of chlorimipramine on DNA synthesis and mitosis in cultured human cells.
Mittwoch, U., & Wilkie, D. R. (1971) · PubMed · Cited by 14
Okadaic acid induces apoptosis in Down syndrome fibroblasts
Dogliotti, G., Galliera, E., Dozio, E., Vianello, E., Villa, R. E., Licastro, F., Barajon, I., & Romanelli, M. M. C. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.12.012 · Cited by 11 · cited 1×
“…carbon 11-labeled Pittsburgh Compound B or a subject with DS and AD (top) and a control without DS Neurology, Nelson LD et al., Positron emission tomogrpahy , 2011, June; 68(6):768–774 with permission from American S, old DS, and AD showing binding characteristics. lines (Dogliotti et al., 2010).”
BackgroundJi, L., Chauhan, V. P. S., Mehta, P. D., Węgiel, J., Mehta, S. P., & Chauhan, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101029 · Cited by 10 · cited 1×
“An alternative explanation may relate to the DYRK1A which is located on chromosome 21 and regulates multiple genes that may contribute to deregulation of neural pathways responsible for dementia (Ji et al., 2010).”
BackgroundKemper, T. L. (1991) · Cerebral cortex · doi:10.1007/978-1-4615-6622-9_12 · Cited by 9
Françoise, a fifteen year follow up
Rondal, J. A., Elbouz, M., Ylieff, M., & Docquier, L. (2002) · Down Syndrome Research and Practice · doi:10.3104/case-studies.135 · Cited by 8 · cited 1×
“Weakness in language abilities of children with DS has been noted (Dykens et al., 2006; Fidler et al., 2005; Rondal et al., 2003).”
BackgroundGlidden, L. M., & Floyd, F. J. (1997) · American Journal on Mental Retardation · doi:10.1352/0895-8017(1997)102
Cited by
Sorted by citations
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
“At the age of 50, typical neuropathological hallmarks of AD appear in DS persons, including deposition of senile plaques containing amyloid β-peptide (Aβ), neurofibrillary tangles composed of hyperphosphorylated tau-P, and cholinergic and serotoninergic reduction (210).”
BackgroundDown syndrome: Cognitive and behavioral functioning across the lifespan
Grieco, J., Pulsifer, M., Seligsohn, K., Skotko, B., & Schwartz, A. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31439 · Cited by 377
Emerging connections between cerebellar development, behaviour and complex brain disorders
Sathyanesan, A., Zhou, J., Scafidi, J., Heck, D. H., Sillitoe, R. V., & Gallo, V. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0152-2 · Cited by 341
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 314
Metadata
- Authors
- Lott, I. T.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Lott, Ira T.
- ORCID
- Lott, Ira T.
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2012
- Volume
- 197
- Pages
- 101-121
- ISSN
- 0079-6123 (ISSN-L)
- PMC
- PMC3417824
- OpenAlex
- W1829879414
- Cited by
- 225
- References
- 163
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 13 · 2023: 14 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 18 · 2016: 13 · 2015: 17 · 2014: 22 · 2013: 10 · 2012: 3
- FWCI
- 38.75
- Type
- book chapter
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Progress in brain research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 21912, P50AG016573, R01AG021912)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065160, HD 37427, HD-065160, R01HD037427)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Down syndrome, neurological phenotype, intellectual disability, brain circuits, hypotonia, infantile spasms, seizures, Alzheimer's disease, dementia, chromosome 21 genes, amyloid-beta, neurodegeneration, glucose metabolism, mitochondrial dysfunction, oxidative stress, sleep apnea, thyroid metabolism, behavioral problems, mouse model, synaptic plasticity, aging
- MeSH terms
- Age Factors, Aging, Brain, Cognition Disorders, Down Syndrome, Humans, Muscle Hypotonia, Nervous System Diseases, Phenotype, Amyloid beta-Peptides, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review